Volume 133, Issue 2, Pages (August 2007)

Slides:



Advertisements
Similar presentations
Volume 138, Issue 1, Pages e1 (January 2010)
Advertisements

Patients With NASH and Cryptogenic Cirrhosis Are Less Likely Than Those With Hepatitis C to Receive Liver Transplants  Jacqueline G. O'Leary, Carmen Landaverde,
Safety and Effectiveness of Direct-Acting Antiviral Agents for Treatment of Patients With Chronic Hepatitis C Virus Infection and Cirrhosis  Raoel Maan,
Thrombocytopenia With Abnormal Liver Function Tests
Ashwin N. Ananthakrishnan, Millie D. Long, Christopher F
Volume 133, Issue 2, Pages (August 2007)
Incidence, Prevalence, and Clinical Significance of Abnormal Hematologic Indices in Compensated Cirrhosis  Amir A. Qamar, Norman D. Grace, Roberto J.
Volume 136, Issue 5, Pages (May 2009)
Predicting outcome after cardiac surgery in patients with cirrhosis: A comparison of Child-Pugh and MELD scores  Amitabh Suman, David S. Barnes, Nizar.
Pancreatic Mass in a Patient With an Increased Serum Level of IgG4
Vasoconstrictor Therapy for the Hepatorenal Syndrome
Rachel H. Westbrook, Andrew D. Yeoman, John G. O'Grady, Phil M
Evaluation and Management of End-Stage Liver Disease in Children
Volume 144, Issue 5, Pages (May 2013)
Volume 146, Issue 5, Pages e1 (May 2014)
Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-analysis  Lorenzo Loffredo, Daniele Pastori,
Volume 136, Issue 5, Pages (May 2009)
Outcomes Among Living Liver Donors
New Model for End Stage Liver Disease Improves Prognostic Capability After Transjugular Intrahepatic Portosystemic Shunt  Jennifer Guy, Ma Somsouk, Stephen.
Volume 140, Issue 7, Pages (June 2011)
Roberts Brown, Jean C. Emond  Gastroenterology 
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Volume 149, Issue 2, Pages (August 2015)
Volume 126, Issue 3, Pages (March 2004)
Liver Cirrhosis Is Associated With Venous Thromboembolism Among Hospitalized Patients in a Nationwide US Study  Harry Wu, Geoffrey C. Nguyen  Clinical.
Volume 137, Issue 5, Pages (November 2009)
Volume 154, Issue 8, Pages e8 (June 2018)
Clinical Challenges and Images in GI
Volume 135, Issue 4, Pages (October 2008)
A Historical Perspective on Clinical Advances in Pancreatic Diseases
Volume 150, Issue 4, Pages (April 2016)
Factors That Predict Outcome of Abdominal Operations in Patients With Advanced Cirrhosis  Dana A. Telem, Thomas Schiano, Robert Goldstone, Daniel K. Han,
Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-analysis  Lorenzo Loffredo, Daniele Pastori,
Issue Highlights Clinical Gastroenterology and Hepatology
Volume 137, Issue 2, Pages (August 2009)
Volume 140, Issue 7, Pages e3 (June 2011)
Volume 134, Issue 5, Pages (May 2008)
Volume 136, Issue 5, Pages (May 2009)
Volume 136, Issue 1, Pages (January 2009)
Volume 146, Issue 5, Pages e6 (May 2014)
Volume 138, Issue 1, Pages e1 (January 2010)
Impact of Liver Disease, Alcohol Abuse, and Unintentional Ingestions on the Outcomes of Acetaminophen Overdose  Robert P. Myers, Abdel Aziz M. Shaheen,
Hepatic Vein Pressure Gradient Reduction and Prevention of Variceal Bleeding in Cirrhosis: A Systematic Review  Gennaro D’Amico, Juan Carlos Garcia-Pagan,
Muscle Wasting Is Associated With Mortality in Patients With Cirrhosis
Volume 144, Issue 1, Pages e1 (January 2013)
Covering the Cover Gastroenterology
Effects of Serum Aspartate Aminotransferase Levels in Patients With Autoimmune Hepatitis Influence Disease Course and Outcome  Thawab Al–Chalabi, James.
Volume 137, Issue 1, Pages (July 2009)
Eric S. Orman, Marwan Ghabril, Naga Chalasani 
Volume 133, Issue 2, Pages (August 2007)
Volume 133, Issue 6, Pages (December 2007)
Ashwin N. Ananthakrishnan, David Lieberman  Gastroenterology 
Patient-Reported Outcomes of Cirrhosis
Volume 148, Issue 3, Pages (March 2015)
Volume 149, Issue 6, Pages (November 2015)
Risk Factors for Mortality After Surgery in Patients With Cirrhosis
Covering the Cover Gastroenterology
Volume 141, Issue 4, Pages (October 2011)
Thrombocytopenia With Abnormal Liver Function Tests
Volume 142, Issue 6, Pages e4 (May 2012)
Hepatitis C Virus Infection, Age, and Hispanic Ethnicity Increase Mortality From Liver Cancer in the United States  Zobair M. Younossi, Maria Stepanova 
Volume 139, Issue 6, Pages e1 (December 2010)
Volume 156, Issue 5, Pages e3 (April 2019)
End-Stage Liver Disease in 2008: Finally a Glass Half Full
Electronic Clinical Challenges and Images in GI
Utility of the MELD score for assessing 3-month survival in patients with liver cirrhosis: one more positive answer  Edoardo Giannini, Federica Botta,
Patients With NASH and Cryptogenic Cirrhosis Are Less Likely Than Those With Hepatitis C to Receive Liver Transplants  Jacqueline G. O'Leary, Carmen Landaverde,
Sildenafil Has No Effect on Portal Pressure but Lowers Arterial Pressure in Patients With Compensated Cirrhosis  Puneeta Tandon, Irteza Inayat, Michael.
Controversies in Liver Transplantation for Hepatitis C
Volume 135, Issue 5, Pages (November 2008)
Presentation transcript:

Volume 133, Issue 2, Pages 481-488 (August 2007) Hepatic Venous Pressure Gradient Predicts Clinical Decompensation in Patients With Compensated Cirrhosis  Cristina Ripoll, Roberto Groszmann, Guadalupe Garcia–Tsao, Norman Grace, Andrew Burroughs, Ramon Planas, Angels Escorsell, Juan Carlos Garcia–Pagan, Robert Makuch, David Patch, Daniel S. Matloff, Jaime Bosch  Gastroenterology  Volume 133, Issue 2, Pages 481-488 (August 2007) DOI: 10.1053/j.gastro.2007.05.024 Copyright © 2007 AGA Institute Terms and Conditions

Figure 1 Flow chart showing the outcome of patients included in the study. Patients who died or received a liver transplant did so without developing cirrhosis decompensation. Gastroenterology 2007 133, 481-488DOI: (10.1053/j.gastro.2007.05.024) Copyright © 2007 AGA Institute Terms and Conditions

Figure 2 ROC curves for cirrhosis decompensation for the main prognostic factors: HVPG, hepatic venous pressure gradient (c statistic, 0.71; 95% CI, 0.64–0.78); albumin, serum albumin (c statistic, 0.66; 95% CI, 0.58–0.74); MELD, model for end-stage liver disease score (c statistic, 0.64; 95% CI, 0.55–0.72); CPS, Child–Pugh score (c statistic, 0.61; 95% CI, 0.52–0.71). Gastroenterology 2007 133, 481-488DOI: (10.1053/j.gastro.2007.05.024) Copyright © 2007 AGA Institute Terms and Conditions

Figure 3 Kaplan–Meier survival curves according to the best cutoff level for (A) HVPG, hepatic venous pressure gradient (best cutoff level is 10 mm Hg); (B) MELD, model for end-stage liver disease (best cutoff score is 10); and (C) serum albumin (best cutoff level is 4 mg/dL). Discontinuous line represents HVPG ≥10 mm Hg, MELD ≥10, albumin <4 g/dL in (A), (B) and (C) respectively. Gastroenterology 2007 133, 481-488DOI: (10.1053/j.gastro.2007.05.024) Copyright © 2007 AGA Institute Terms and Conditions